NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.00
-0.76 (-2.95%)
Aug 14, 2025, 2:17 PM - Market open
NAMS Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$41.00
Upside
+64.00%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $38 → $39 | Buy | Maintains | $38 → $39 | +56.00% | Aug 7, 2025 |
Goldman Sachs | Goldman Sachs | Hold Initiates $27 | Hold | Initiates | $27 | +8.00% | Jul 17, 2025 |
Citigroup | Citigroup | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +68.00% | Jun 17, 2025 |
Needham | Needham | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +60.00% | Jun 12, 2025 |
Stifel | Stifel | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +76.00% | Jun 10, 2025 |
Needham | Needham | Strong Buy Maintains $42 → $40 | Strong Buy | Maintains | $42 → $40 | +60.00% | May 8, 2025 |
Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +68.00% | Apr 8, 2025 |
Scotiabank | Scotiabank | Buy Maintains $47 → $52 | Buy | Maintains | $47 → $52 | +108.00% | Feb 27, 2025 |
Needham | Needham | Strong Buy Maintains $46 → $42 | Strong Buy | Maintains | $46 → $42 | +68.00% | Feb 27, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +60.00% | Jan 28, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +60.00% | Jan 24, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +92.00% | Jan 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +92.00% | Dec 30, 2024 |
Scotiabank | Scotiabank | Buy Maintains $35 → $47 | Buy | Maintains | $35 → $47 | +88.00% | Dec 11, 2024 |
Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +44.00% | Dec 5, 2024 |
Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +44.00% | Nov 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.